Evaluation of multiple sclerosis by H-1 spectroscopic imaging at 4.1 T

被引:68
作者
Pan, JW
Hetherington, HP
Vaughan, JT
Mitchell, G
Pohost, GM
Whitaker, JN
机构
[1] UNIV ALABAMA,DEPT NEUROL,BIRMINGHAM,AL 35294
[2] UNIV ALABAMA,CTR VET MED,RES SERV,BIRMINGHAM,AL 35294
[3] UNIV ALABAMA,DEPT MED,DIV CARDIOVASC DIS,BIRMINGHAM,AL 35294
关键词
multiple sclerosis; magnetic resonance spectroscopy; N-acetylaspartate; creatine;
D O I
10.1002/mrm.1910360113
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The authors report on high-field (4.1 T) magnetic resonance H-1 spectroscopic imaging studies on eight patients with relapsing remitting multiple sclerosis (mean expanded disability status scale (EDSS) 1.0) and eight normal controls. Using T-1-weighted imaging to determine lesion position, the authors found the ratios of choline/N-acetyl (NA) compounds and creatine/NA were increased significantly in the multiple sclerosis (MS) patients relative to controls in lesioned tissue, adjacent to lesion, far removed from lesions as well as in periventricular tissue. The gray matter creatine/NA was mildly increased (P < 0.01) in the MS patients, whereas the elevated gray-matter ratio of choline/NA was of borderline significance (P = 0.13), A more detailed comparison of white-matter and mean gray-matter metabolite values indicates that creatine is increased greatest in areas far from lesions. This is in contrast to choline, which was greatest in lesions, and NA, which was smallest in lesions. It is postulated that the creatine increase may reflect an astrocytic (gliotic) or oligodendrocytic remyelinating process. The increased choline most likely reflects varying levels of inflammation and membrane turnover, whereas the NA decrease is representative of axonal dysfunction or loss.
引用
收藏
页码:72 / 77
页数:6
相关论文
共 28 条
  • [1] HISTOLOGICAL, HISTOCHEMICAL AND BIOCHEMICAL-STUDY OF THE MACROSCOPICALLY NORMAL WHITE MATTER IN MULTIPLE-SCLEROSIS
    ALLEN, IV
    MCKEOWN, SR
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 1979, 41 (01) : 81 - 91
  • [2] PROTON MAGNETIC-RESONANCE SPECTROSCOPY OF HUMAN BRAIN INVIVO IN THE EVALUATION OF MULTIPLE-SCLEROSIS - ASSESSMENT OF THE LOAD OF DISEASE
    ARNOLD, DL
    MATTHEWS, PM
    FRANCIS, G
    ANTEL, J
    [J]. MAGNETIC RESONANCE IN MEDICINE, 1990, 14 (01) : 154 - 159
  • [3] USE OF PROTON MAGNETIC-RESONANCE SPECTROSCOPY FOR MONITORING DISEASE PROGRESSION IN MULTIPLE-SCLEROSIS
    ARNOLD, DL
    RIESS, GT
    MATTHEWS, PM
    FRANCIS, GS
    COLLINS, DL
    WOLFSON, C
    ANTEL, JP
    [J]. ANNALS OF NEUROLOGY, 1994, 36 (01) : 76 - 82
  • [4] PROTON MAGNETIC-RESONANCE SPECTROSCOPIC IMAGING FOR METABOLIC CHARACTERIZATION OF DEMYELINATING PLAQUES
    ARNOLD, DL
    MATTHEWS, PM
    FRANCIS, GS
    OCONNOR, J
    ANTEL, JP
    [J]. ANNALS OF NEUROLOGY, 1992, 31 (03) : 235 - 241
  • [5] PERIVENTRICULAR PLAQUES IN MULTIPLE-SCLEROSIS - IRREVERSIBLE - AN MRI FOLLOW-UP-STUDY
    BAUM, K
    NEHRIG, C
    SCHORNER, W
    GIRKE, W
    [J]. EUROPEAN NEUROLOGY, 1992, 32 (04) : 219 - 221
  • [6] BRENNER RE, P SMRM 12 ANN M 1993, P281
  • [7] SERIAL PROTON MAGNETIC-RESONANCE SPECTROSCOPY IN ACUTE MULTIPLE-SCLEROSIS LESIONS
    DAVIE, CA
    HAWKINS, CP
    BARKER, GJ
    BRENNAN, A
    TOFTS, PS
    MILLER, DH
    MCDONALD, WI
    [J]. BRAIN, 1994, 117 : 49 - 58
  • [8] GREENFIELD, 1992, TXB NEUROPATHOLOGY, P464
  • [9] GROSSMAN RI, 1992, AM J NEURORADIOL, V13, P1535
  • [10] 2D H-1 SPECTROSCOPIC IMAGING OF THE HUMAN BRAIN AT 4.1-T
    HETHERINGTON, HP
    PAN, JW
    MASON, GF
    PONDER, SL
    TWIEG, DB
    DEUTSCH, G
    MOUNTZ, J
    POHOST, GM
    [J]. MAGNETIC RESONANCE IN MEDICINE, 1994, 32 (04) : 530 - 534